TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer. [electronic resource]
Producer: 20151102Description: 4527 p. digitalISSN:- 2041-1723
- ATPases Associated with Diverse Cellular Activities
- Animals
- Antineoplastic Agents -- pharmacology
- Carcinoma, Squamous Cell -- drug therapy
- Carrier Proteins -- antagonists & inhibitors
- Cell Cycle Proteins
- Cell Line, Transformed
- Cell Line, Tumor
- Cell Movement
- Cell Transformation, Neoplastic -- genetics
- Chick Embryo
- Chorioallantoic Membrane -- blood supply
- DNA Breaks, Double-Stranded
- DNA End-Joining Repair
- DNA-Activated Protein Kinase -- antagonists & inhibitors
- Drug Resistance, Neoplasm -- genetics
- Gene Expression Regulation, Neoplastic
- Head and Neck Neoplasms -- drug therapy
- Humans
- Injections, Subcutaneous
- Keratinocytes -- drug effects
- Mice
- Mice, Nude
- NIH 3T3 Cells
- Nuclear Proteins -- antagonists & inhibitors
- RNA, Small Interfering -- genetics
- Signal Transduction
- Squamous Cell Carcinoma of Head and Neck
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.